Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study

被引：0

作者：

Menzies-Gow, Andrew ^{[1
]}

Corren, Jonathan ^{[2
]}

Bourdin, Arnaud ^{[3
]}

Chupp, Geoffrey ^{[4
]}

Israel, Elliot ^{[5
,6
]}

Griffiths, Janet ^{[7
]}

Hellqvist, Asa ^{[8
]}

Bowen, Karin ^{[9
]}

Kaur, Primal ^{[10
]}

Almqvist, Gun ^{[11
]}

Ponnarambil, Sandhia ^{[12
]}

Colice, Gene ^{[13
]}

机构：

[1] Royal Brompton Hosp, London, England

[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[3] CHU Montpellier, Hop Arnaud Villeneuve, Montpellier, France

[4] Yale Sch Med, New Haven, CT USA

[5] Harvard Med Sch, Boston, MA 02115 USA

[6] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

[7] AstraZeneca, Translat Sci & Expt Med, Res & Early Dev, Resp & Immunol,BioPharmaceut R&D, Gaithersburg, MD USA

[8] AstraZeneca, BioPharmaceut R&D, Biometr Late Resp & Immunol, Gothenburg, Sweden

[9] Astrazeneca, BioPharmaceuticals R&D, Biometr Late Resp & Immunol, Gaithersburg, MD USA

[10] Amgen Inc, Thousand Oaks, CA USA

[11] AstraZeneca, Late Resp & Immunol, BioPharmaceut R&D, Gothenburg, Sweden

[12] AstraZeneca, BioPharmaceut R&D, Late Resp & Immunol, Cambridge, England

[13] AstraZeneca, Resp & Immunol, BioPharmaceut R&D, Gaithersburg, MD USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2021年 / 147卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

L46

引用

页码：AB249 / AB249

页数：1

共 50 条

[1] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma by Sex: Results From the Phase 3 Navigator Study
Kraft, M.
Chupp, G. L.
Reeh, K.
Lindsley, A. W.
Cook, B.
Hunter, G.
Ambrose, C. S.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
[2] Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with Respiratory Comorbidities: Results from the Phase 3 NAVIGATOR Study
Carr, Tara
Bernstein, Jonathan
Cook, Bill
Hunter, Gillian
Ambrose, Chris
Llanos-Ackert, Jean-Pierre
Lindsley, Andrew
Colice, Gene
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB152 - AB152
[3] Tezepelumab Treatment Reduced Asthma Symptomatic Days in Adults and Adolescents with Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
Carr, Warner
Jain, Neal
Ambrose, Chris
Clarke, Nicole
Martin, Neil
Kmita, Kamil
Desai, Pooja
Llanos-Ackert, Jean-Pierre
Ponnarambil, Sandhia
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB16 - AB16
[4] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA GROUPED BY NUMBER OF ADDITIONAL ASTHMA CONTROLLER MEDICATIONS: RESULTS FROM THE PHASE 3 NAVIGATOR STUDY
Kraft, Monica
Colice, Gene L.
Ambrose, Christopher
Cook, William
Hunter, Gillian
Molfino, Eleonora A.
Martin, Neil
Roseti, Stephanie L.
[J]. CHEST, 2022, 162 (04) : 11A - 12A
[5] Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma
Menzies-Gow, Andrew
Corren, Jonathan
Bourdin, Arnaud
Chupp, Geoffrey
Israel, Elliot
Wechsler, Michael E.
Brightling, Christopher E.
Griffiths, Janet M.
Hellqvist, Asa
Bowen, Karin
Kaur, Primal
Almqvist, Gun
Ponnarambil, Sandhia
Colice, Gene
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (19): : 1800 - 1809
[6] Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR study
Corren, Jonathan
Ambrose, Christopher S. S.
Griffiths, Janet M. M.
Hellqvist, Asa
Lindsley, Andrew W. W.
Llanos, Jean-Pierre
Colice, Gene
Menzies-Gow, Andrew
[J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (04): : 417 - 428
[7] Efficacy of tezepelumab in adolescents with severe, uncontrolled asthma
Israel, Elliot
Menzies-Gow, Andrew
Chupp, Geoffrey
Ambrose, Chris
Cook, Bill
Hunter, Gillian
Llanos-Ackert, Jean-Pierre
Downie, John
Colice, Gene
[J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
[8] Tezepelumab in Adults and Adolescents with severe, uncontrolled Asthma
不详
[J]. ALLERGOLOGIE, 2021, 44 (08) : 577 - 578
[9] Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study
Hoyte, Flavia
Martin, Neil
Kmita, Kamil
Roseti, Stephanie
Llanos-Ackert, Jean-Pierre
Lindsley, Andrew
Colice, Gene
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB63 - AB63
[10] Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
Menzies-Gow, Andrew
Ambrose, Christopher S.
Colice, Gene
Hunter, Gillian
Cook, Bill
Molfino, Nestor A.
Llanos, Jean-Pierre
Israel, Elliot
[J]. ADVANCES IN THERAPY, 2023, 40 (11) : 4957 - 4971

← 1 2 3 4 5 →